Featured Research

from universities, journals, and other organizations

New Step Toward Treatment For Duchenne Muscular Dystrophy

Date:
June 11, 2006
Source:
Université Laval
Summary:
Researchers in Quebec, Canada, have taken an important step toward a cure for Duchenne muscular dystrophy. After performing the first successful muscle cell transplant in young patients two years ago, the researchers have announced that eight out of the nine patients have shown promising results.

Professor Jacques P. Tremblay, Université Laval and Centre Hospitalier Universitaire de Québec.
Credit: Université Laval, Marc Robitaille

A team led by Dr. Jacques P. Tremblay, a researcher with the Human Genetics Department at Quebec City's Centre Hospitalier Universitaire de Québec (CHUQ) and professor with Université Laval's Faculty of Medicine, has taken an important step toward a cure for Duchenne muscular dystrophy. After performing the first successful muscle cell transplant in young patients two years ago, professor Tremblay announced that eight out of the nine patients have shown promising results.

Duchenne muscular dystrophy is a progressive weakening and degeneration of the muscles, caused by a mutation in a gene coding for a protein called dystrophin. This protein is absent in the muscles of people affected with the disorder. With the healthy muscle cells grafted by the team of researchers, a considerable proportion of patients' muscle fibers are now able to synthesize the missing protein. Analyses showed that between 4% and 26% of muscle cells in the cubic centimeter of treated muscle eventually produce the protein produced by the fusion of the donor cells. The results are published in the latest issue of the Journal of Neuropathology and Experimental Neurology. Dr. Tremblay's team is the first in the world to achieve this level of dystrophin expression in so many patients, and in such a high percentage of fibers.

Duchenne muscular dystrophy is a hereditary disease affecting one boy in 3,500. The first signs appear in childhood, between the ages of two and five. Its victims are confined to a wheelchair by their early teens. The disease progressively weakens all muscles, notably respiratory muscles, compromising life expectancy. Most sufferers die between the ages of 20 and 30. Today, there is no treatment--only rehabilitation, surgical procedures and prednisone to enhance patients' quality of life.

New clinical trial: seeking ten patients

Based on these results, professor Tremblay has received authorization to conduct a second round of clinical trials. These new trials are supported financially by SOVAR, CellGene Inc., and Association Française contre les Myopathies. In this second trial, some 300 million donor cells will be transplanted into a complete muscle in the recipient's forearm. Patients' strength will be measured before their grafts, then three and six months after. This experiment will enable researchers to determine whether the transplant significantly increases the strength of the grafted muscle.

Dr. Tremblay's team is seeking ten patients over the age of 18 who suffer from Duchenne or Becker muscular dystrophy. Patients are asked to talk to their neurologists, who can help them contact the researchers.

Dr. Tremblay received the 2005 Sirius research award for his work on Duchenne muscular dystrophy. More recently, the Royal College of Physicians and Surgeons of Canada and the Canadian Society for Clinical Investigation together awarded him the Henry-Friesen Award honoring a distinguished scientist whose biomedical research is recognizable on the international stage as novel and original and of the highest caliber.

The multidisciplinary CHUQ team headed by Dr. Jacques P. Tremblay includes Dr. Daniel Skuk, Dr. Michel Sylvain, Dr. Jack Puymirat, Dr. Jean-Pierre Bouchard, Dr. Louise Deschènes, Dr. Hélène Senay, Dr. Jean-Guy Lachance, Dr. Raynald Roy, and Dr. Pierre Dalens.


Story Source:

The above story is based on materials provided by Université Laval. Note: Materials may be edited for content and length.


Cite This Page:

Université Laval. "New Step Toward Treatment For Duchenne Muscular Dystrophy." ScienceDaily. ScienceDaily, 11 June 2006. <www.sciencedaily.com/releases/2006/06/060609093431.htm>.
Université Laval. (2006, June 11). New Step Toward Treatment For Duchenne Muscular Dystrophy. ScienceDaily. Retrieved September 2, 2014 from www.sciencedaily.com/releases/2006/06/060609093431.htm
Université Laval. "New Step Toward Treatment For Duchenne Muscular Dystrophy." ScienceDaily. www.sciencedaily.com/releases/2006/06/060609093431.htm (accessed September 2, 2014).

Share This




More Health & Medicine News

Tuesday, September 2, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

U.N. Says Ebola Travel Restrictions Will Cause Food Shortage

U.N. Says Ebola Travel Restrictions Will Cause Food Shortage

Newsy (Sep. 2, 2014) — The U.N. says the problem is two-fold — quarantine zones and travel restrictions are limiting the movement of both people and food. Video provided by Newsy
Powered by NewsLook.com
Get on Your Bike! London Cycling Popularity Soars Despite Danger

Get on Your Bike! London Cycling Popularity Soars Despite Danger

AFP (Sep. 1, 2014) — Wedged between buses, lorries and cars, cycling in London isn't for the faint hearted. Nevertheless the number of people choosing to bike in the British capital has doubled over the past 15 years. Duration: 02:27 Video provided by AFP
Powered by NewsLook.com
Can You Train Your Brain To Eat Healthy?

Can You Train Your Brain To Eat Healthy?

Newsy (Sep. 1, 2014) — New research says if you condition yourself to eat healthy foods, eventually you'll crave them instead of junk food. Video provided by Newsy
Powered by NewsLook.com
We've Got Mites Living In Our Faces And So Do You

We've Got Mites Living In Our Faces And So Do You

Newsy (Aug. 30, 2014) — A new study suggests 100 percent of adult humans (those over 18 years of age) have Demodex mites living in their faces. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins